BioCentury
ARTICLE | Company News

Affibody, Swedish Orphan Biovitrum deal

July 16, 2012 7:00 AM UTC

The companies partnered to discover and develop up to five treatments for autoimmune and inflammatory diseases where IL-1 is implicated. Swedish Orphan has a two-year option to license programs develo...